Trials / Completed
CompletedNCT03704623
Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic
Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Due to Ureteric Calculi: Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to compare the efficacy and safety of Parecoxib versus Paracetamol for treatment of acute renal colic due to ureteric stones.
Detailed description
Eligible patients will be randomized to one of the two treatment groups. Group 1 patients will receive IV 1 g of Paracetamol while group 2 patients will receive 40 mg of Parecoxib IV. The Visual Analogue Scale (VAS) will be calculated on presentation and at 30 minutes after analgesia administration. Patients who do not respond to an initial dose of the analgesia will receive rescue analgesia in the form of Morphine, 01.mg/kg, IV.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracetamol | Paracetamol 1g IV |
| DRUG | Parecoxib | Parecoxib 40 mg IV |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2020-08-15
- Completion
- 2020-08-15
- First posted
- 2018-10-15
- Last updated
- 2020-08-28
Locations
1 site across 1 country: Kuwait
Source: ClinicalTrials.gov record NCT03704623. Inclusion in this directory is not an endorsement.